16562-77-9

Basic information

• Product Name: sodium 2-oxopropanesulphonate
• Synonyms: Sodium 2-oxopropanesulfonate;sodium 2-oxopropanesulphonate;2-Oxo-1-propanesulfonic acid sodium salt
• CAS NO: 16562-77-9
• Molecular Formula: C₃H₅O₄S*Na
• Molecular Weight: 160.12417
• EINECS: 240-626-3
• Mol File: 16562-77-9.mol
• Article Data: 7

Chemical Properties

• Melting Point: 173-180 °C
• Appearance: /
• CAS DataBase Reference: sodium 2-oxopropanesulphonate(CAS DataBase Reference)
• NIST Chemistry Reference: sodium 2-oxopropanesulphonate(16562-77-9)
• EPA Substance Registry System: sodium 2-oxopropanesulphonate(16562-77-9)

Safety Data

• Hazardous Substances Data: 16562-77-9(Hazardous Substances Data)

Usage

Description

Sodium 2-oxopropanesulphonate, also known as sodium acetonesulfonate, is an organic compound that serves as an intermediate in the synthesis of various chemical compounds. It is a white crystalline solid with the chemical formula C3H5NaO5S.

Uses

Used in Chemical Synthesis:
Sodium 2-oxopropanesulphonate is used as an intermediate in the synthesis of Sodium Dibromomethanesulfonate (S624110). sodium 2-oxopropanesulphonate is utilized in the preparation of halogenated alkyl sulfonic acids, which are essential in the production of Rontgen photographs of urogenital organs.

InChI:InChI=1/C3H6O4S.Na/c1-3(4)2-8(5,6)7;/h2H2,1H3,(H,5,6,7);/q;+1/p-1

Upstream product

• 598-31-2 1-bromoacetone 
• 78-95-5 chloroacetone 

Downstream Products

• 127-09-3 sodium acetate 
• 2386-57-4 methanesulfonic acid sodium salt 

Relevant articles and documents

Synthetic Studies towards CH-Diazomethane Sulfonamides: a Novel Type of Diazo Reagents

Preparation of CH-diazomethane sulfonamides has been developed for the first time. Their utility as a new type of diazo reagents was showcased in cycloaddition reactions with electron-deficient alkynes and β-nitro styrenes which delivered medicinally important pyrazole-3-sulfonamides in good to excellent yields.

PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES

Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.

NOVEL INHIBITORS OF PROTEIN KINASES

Protein kinases are regulators of cellular signaling and their functional dysregulation is common in carcinogenesis and many other disease states or disorders. The present invention relates to novel chemical entities that have biological activity to modulate mammalian protein kinase enzymes. In particular, compounds of the invention display potent inhibition of breast tumor related kinase (BRK).